Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03400371 · ClinicalTrials.gov registry record
Biology of Juvenile Myoclonic Epilepsy
A clinical trial of Juvenile Myoclonic Epilepsy, sponsored by King's College London.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 15
- Study locations
NCT03400371 is a study of Juvenile Myoclonic Epilepsy that is actively recruiting participants, run by King's College London. The registered enrollment target is 1,000 participants. The trial reports 15 study locations across 4 states.
The verdict
NCT03400371, a study of Juvenile Myoclonic Epilepsy, is actively recruiting participants, sponsored by King's College London.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 15
- Study locations
Study Summary
The investigators are collecting genetic information through blood samples as well as clinical and EEG data from over 1000 people with Juvenile Myoclonic Epilepsy (JME) across the UK, Europe and North America. This study will draw on both existing and new samples from JME patients. These will be compared to anonymised data from samples for 2000 controls. The goal of this study is to find the genetic cause of JME. Finding the cause will help create better treatments for JME, as well as improve patient outcomes by allowing us to detect it earlier.
Conditions Studied
Interventions
- OTHER Blood draw
- OTHER Existing samples
Study Locations (15)
Other
- Charles University - Prague
- Danish National Epilepsy Centre - Dianalund
- Tallinn Children's Hospital - Tallinn
- University Robert Debré - Paris
- Commissione Genetica Lega Italiana contro l'Epilepssia - Roma
- Vestre Viken Health Trust, Oslo - Drammen
- Walton Centre for Neurology and Neurosurgery - Liverpool
- Royal London Hospital - London
- St Thomas' Hospital - London
- King's College Hospital NHS Trust - London
- Swansea University - Swansea
New York
- Mount Sinai-Beth Israel Medical Center - New York
- St Luke's Roosevelt Hospital - New York
Ohio
- Nationwide Children's Hospital - Columbus
Ontario
- Hospital for Sick Kids - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2017-07-13 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03400371
The ClinicalTrials.gov registry entry for NCT03400371 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is King's College London, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Juvenile Myoclonic Epilepsy appearing as the primary indexed condition, and to 2 interventions - of which Blood draw is the first listed.
NCT03400371 reports 15 study locations spanning 4 distinct geographic areas - top geographies include Other, New York, Ohio.
Frequently Asked Questions
What is clinical trial NCT03400371 about?
NCT03400371 is a clinical study titled "Biology of Juvenile Myoclonic Epilepsy". The investigators are collecting genetic information through blood samples as well as clinical and EEG data from over 1000 people with Juvenile Myoclonic Epilepsy (JME) across the UK, Europe and North America. This study will draw on both existing and new samples from JME patients. These will be com...
What is the current status of trial NCT03400371?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2017-07-13. Estimated completion is 2026-12-31.
What conditions does trial NCT03400371 study?
This clinical trial studies the following conditions: Juvenile Myoclonic Epilepsy.
What interventions are being tested in trial NCT03400371?
The interventions under investigation include: Blood draw (OTHER), Existing samples (OTHER).
Who is sponsoring clinical trial NCT03400371?
This trial is sponsored by King's College London, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03400371 being conducted?
This trial has 15 study locations across New York, Ohio, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.